Cargando…
α‐Mangostin‐encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway
Colorectal cancer (CRC) is the fourth leading cause of cancer‐related mortality. Recent studies have stated that Notch signalling is highly activated in cancer stem cells (CSCs) and plays an important role in the development and progression of CRC. Like normal colorectal epithelium, CRCs are organiz...
Autores principales: | Chandra Boinpelly, Varun, Verma, Raj K., Srivastav, Sudesh, Srivastava, Rakesh K., Shankar, Sharmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576287/ https://www.ncbi.nlm.nih.gov/pubmed/32830433 http://dx.doi.org/10.1111/jcmm.15731 |
Ejemplares similares
-
α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice
por: Verma, Raj Kumar, et al.
Publicado: (2016) -
Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog
por: Ma, Yiming, et al.
Publicado: (2019) -
SATB2 is a novel biomarker and therapeutic target for cancer
por: Roy, Sanjit K., et al.
Publicado: (2020) -
Potential of Alpha-Mangostin-Loaded PLGA Nanoparticles for Cholangiocarcinoma Treatment
por: Tahir, Asma, et al.
Publicado: (2022) -
Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
por: Roy, Sanjit K., et al.
Publicado: (2023)